Read more

January 20, 2021
1 min read
Save

Top in endocrinology: Cognitive decline during menopause, premeal ketone drinks

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

A recent study showed that cognitive impairment may worsen with menopause stage. It was the top story in endocrinology last week.

An analysis investigating the benefits of a premeal ketone drink in patients with obesity was another top story.

Menopause Adobe
Source: Adobe Stock

Read these and more news in endocrinology below:

Cognitive impairment may worsen with menopause stage

A cohort of women experienced declines in three cognitive domains associated with menopause stage, independent of age and other factors, including HIV status, according to findings published in Menopause. Read more.

Premeal ketone drink improves glucose, endothelial function in obesity

Adults with obesity saw improvements in glycemic response and endothelial function after a 14-day intervention with a ketone monoester drink consumed before each meal, data from a small study show. Read more.

Different forms of sugar influence hunger response in young adults

Table sugar may be less efficient in provoking a satiety response compared with oral glucose, and individual biological factors also influence peripheral hormone responses to sucrose vs. glucose consumption, study data show. Read more.

More visceral fat increases risk for COVID-19 ICU admission, mechanical ventilation

Individuals with COVID-19 who are admitted to the ICU or treated with invasive mechanical ventilation have more visceral fat than those who are admitted to the hospital, but are not in critical condition, according to study data. Read more.

Metabolic improvements seen 26 weeks after fecal microbiome transfer for teens

Fecal microbiome transfer led to a mean reduction in android-to-gynoid fat ratio and a resolution of metabolic syndrome in a cohort of adolescents with obesity, according to randomized controlled trial data published in JAMA Network Open. Read more.